Yirme Galia, Amit Michal, Laevsky Ilana, Osenberg Sivan, Itskovitz-Eldor Joseph
Biotechnology Interdisciplinary Unit, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Stem Cells Dev. 2008 Dec;17(6):1227-41. doi: 10.1089/scd.2007.0272.
The promise of human embryonic stem cells (hESCs) to provide an unlimited supply of cells for cell therapy depends on the availability of a controllable bioprocess for their expansion and differentiation. We describe here a robust and well-defined scale up platform for human embryoid body (EB) formation, propagation, and differentiation. The efficacy of the dynamic process as compared to the static cultivation in Petri dishes was analyzed. Our optimized conditions include specific bioreactor and impeller type, seeding and propagation parameters, and scale up. Quantitative analyses of viable cell concentrations, apoptosis percentages, and EB yield revealed 6.7-fold enhancement in the generation of hESC-derived cells after 10 cultivation days. Other metabolic indices such as glucose consumption, lactic acid production and pH all pointed to efficient cell expansion in the dynamic cultures. The hydrodynamic conditions during seeding and cultivation were found to be crucial for the EB formation and propagation. The EBs' prearrangement in the static system and EB cultivation in the Glass Ball Impeller spinner flask resulted in high EB yield, a round homogenous shape, and the fastest growth rate. The appearance of representative genes of the three germ layers as well as primitive neuronal tube organization and blood vessel formation indicated that the initial developmental events in the human EBs are not interfered by the dynamic system. Furthermore, well developed endothelial networks and contracting EBs with functional cardiac muscle were also obtained after two cultivation weeks. Collectively, our study defines the technological platform for the controlled large-scale generation of hESC-derived cells for clinical and industrial applications.
人类胚胎干细胞(hESCs)有望为细胞治疗提供无限的细胞供应,这取决于是否有可控的生物过程来实现其扩增和分化。我们在此描述了一个强大且定义明确的用于人类胚状体(EB)形成、增殖和分化的放大平台。分析了动态过程与在培养皿中静态培养相比的效果。我们优化的条件包括特定的生物反应器和搅拌器类型、接种和增殖参数以及放大。对活细胞浓度、凋亡百分比和EB产量的定量分析显示,在培养10天后,hESC衍生细胞的生成增加了6.7倍。其他代谢指标,如葡萄糖消耗、乳酸产生和pH值,都表明动态培养中细胞的有效扩增。发现接种和培养过程中的流体动力学条件对EB的形成和增殖至关重要。在静态系统中对EB进行预排列,并在玻璃球搅拌器旋转瓶中培养EB,可获得高EB产量、圆形均匀形状和最快的生长速度。三个胚层代表性基因的出现以及原始神经管组织和血管形成表明,人类EB中的初始发育事件不受动态系统干扰。此外,在培养两周后还获得了发育良好的内皮网络和具有功能性心肌的收缩性EB。总之,我们的研究定义了用于临床和工业应用的可控大规模生成hESC衍生细胞的技术平台。